Ranibizumab is a potential prophylaxis for proliferative vitreoretinopathy, a nonangiogenic blinding disease
Pennock, Steven, David Kim, Shizuo Mukai, Matthew Kuhnle, Dal Chun, Joanne Matsubara, Jing Cui, et al. 2013. “Ranibizumab Is a Potential Prophylaxis for Proliferative Vitreoretinopathy, a Nonangiogenic Blinding Disease”. Am J Pathol 182 (5): 1659-70.